Mr. Douglas J. Langa, also known as Doug, has been the President at Novo Nordisk, Inc. since March 1. 2017 and has been its Executive Vice President of North America Operations since August 21, 2017. Mr. Langa served as Head of North America Operations and Senior Vice President at Novo Nordisk, Inc. He served as Senior Vice President and Head of North America Operations at Novo Nordisk A/S since March 2017 until August 15, 2017. Mr. Langa served as Senior Vice President, Market Access, where he was responsible for securing formulary access with key payer customers for Novo Nordisk brands. The Market Access function at Novo Nordisk covers payer marketing, contract strategy, pricing and account management for all promoted and in-line brands. Under Mr. Langa’s leadership, the Market Access account executive team has received numerous third-party recognitions for their performance allowing a broad number of patients with chronic diseases to benefit from having access to Novo Nordisk brands. He joined Novo Nordisk from GlaxoSmithKline where he was senior director of Payer Marketing. Mr. Langa spent the majority of his career at Johnson & Johnson, where he held various roles of increasing responsibility within Managed Markets, Sales Leadership and Marketing. He has over 25 years of experience in the pharmaceutical and medical device industry. He holds professional certificates from The Wharton School and Harvard Business School. Mr. Langa graduated from Widener University in 1989 and earned his MBA from Fordham University in 1997.

 Marketing and Finance